Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Amgen and Regeneron Pharmaceuticals

Continue Reading

Analysts Predict Bullish Short-Term Outlook for Gold as Lawmakers Look to Avoid “Fiscal Cliff”

The Paragon Report Provides Stock Research on Eldorado Gold and New Gold

Continue Reading

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Orexigen Therapeutics and PDL BioPharma

Continue Reading

Increased Iron Ore Demand From China in the Fourth Quarter to Help Ease Shipping Industry-s Oversupply

Five Star Equities Provides Stock Research on Navios Maritime and Overseas Shipholding Group

Continue Reading

Arena Pharmaceuticals and VIVUS Look to Benefit as Aetna Provides Coverage for Anti-Obesity Drugs

Five Star Equities Provides Stock Research on Arena Pharmaceuticals and VIVUS

Continue Reading

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Complete Genomics and Exelixis

Continue Reading

Gold Futures Surge to 1 Month Highs on Optimism That the Upcoming “Fiscal Cliff” Can Be Avoided

The Paragon Report Provides Stock Research on Brigus Gold and Jaguar Mining

Continue Reading

Medical Devices Industry Profits to Take a Blow With the Implementation of Medical Device Excise Tax

The Paragon Report Provides Stock Research on Boston Scientific and Medtronic

Continue Reading

Short-Term Outlook for Gold Bullish as Lawmakers Seek to Find Solution for Upcoming “Fiscal Cliff”

The Paragon Report Provides Stock Research on Harmony Gold Mining and Rubicon Minerals

Continue Reading

Medical Device Excise Tax to Have a Significant Impact on Industry Profits in the New Year

The Paragon Report Provides Stock Research on St. Jude Medical and Sunshine Heart

Continue Reading